Related Experiment Videos
["Ghost and mimicry-tumor"--primary CNS lymphoma]
J G Heckmann1, A Druschky, P M Kern
1Neurologische Universitätsklinik, Erlangen-Nürnberg.
Der Nervenarzt
|May 5, 2000
Summary
Primary cerebral lymphoma (PCNSL) can mimic other neurological conditions and may temporarily respond to steroids. Early biopsy is crucial for accurate diagnosis and effective treatment of PCNSL in immunocompetent patients.
Area of Science:
- Neuro-oncology
- Neuropathology
- Diagnostic Neurology
Background:
- Primary CNS lymphoma (PCNSL) incidence is rising, even in immunocompetent individuals.
- Early diagnosis of PCNSL is critical for effective treatment and improved patient outcomes.
- PCNSL can present with diverse and atypical clinical manifestations, complicating diagnosis.
Observation:
- Three cases of PCNSL with unusual presentations are detailed, highlighting diagnostic challenges.
- Patient 1 experienced tumor remission with steroid therapy, initially mimicking other conditions.
- Patients 2 and 3 presented with symptoms that delayed PCNSL diagnosis, including hearing loss and cognitive decline.
Findings:
- PCNSL can exhibit transient remission with corticosteroid treatment, mimicking other neurological diseases.
- Atypical symptoms and steroid responsiveness can delay the definitive diagnosis of PCNSL.
- Histopathological confirmation via biopsy is essential for accurate PCNSL diagnosis.
Implications:
- PCNSL should be considered in the differential diagnosis of unexplained neurological deficits, especially when presenting atypically.
- The potential for steroid-induced remission in PCNSL underscores the need for early and definitive diagnostic procedures.
- Timely biopsy in cases of unclear cerebral lesions is paramount for initiating appropriate oncological treatment and improving prognosis.